Group One Trading, L.P. Pmv Pharmaceuticals, Inc. Transaction History
Group One Trading, L.P.
- $2.68 Billion
- Q2 2025
A detailed history of Group One Trading, L.P. transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 7,396 shares of PMVP stock, worth $9,984. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,396
Previous 11,296
34.53%
Holding current value
$9,984
Previous $12,000
41.67%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding PMVP
# of Institutions
61Shares Held
37.4MCall Options Held
100Put Options Held
0-
Orbimed Advisors LLC San Diego, CA6.48MShares$8.74 Million0.25% of portfolio
-
Bml Capital Management, LLC Zionsville, IN5MShares$6.75 Million4.01% of portfolio
-
Sio Capital Management, LLC New York, NY3.74MShares$5.04 Million1.89% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.19MShares$4.3 Million0.07% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$3.55 Million0.92% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $61.6M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...